nickel has been researched along with ucn 1028 c in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiroishi, G; Inomata, H; Kanaide, H; Kobayashi, S; Nishimura, J | 1 |
| Chakrabarti, R; Kumar, S | 1 |
| Hill-Eubanks, LJ; Jones, SV; Pemberton, KE | 1 |
3 other study(ies) available for nickel and ucn 1028 c
| Article | Year |
|---|---|
High D-glucose stimulates the cell cycle from the G1 to the S and M phases, but has no competent effect on the G0 phase, in vascular smooth muscle cells.
Topics: Animals; Aorta; Becaplermin; Cell Cycle; Cells, Cultured; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; G1 Phase; Glucose; Humans; Ki-67 Antigen; Kinetics; Male; Mannitol; Mitosis; Muscle, Smooth, Vascular; Naphthalenes; Neoplasm Proteins; Nickel; Nuclear Proteins; Platelet-Derived Growth Factor; Polycyclic Compounds; Proliferating Cell Nuclear Antigen; Protein Kinase C; Proto-Oncogene Proteins c-sis; Rats; Rats, Wistar; Recombinant Proteins; Resting Phase, Cell Cycle; S Phase; Stereoisomerism; Time Factors | 1995 |
Diacylglycerol mediates the T-cell receptor-driven Ca(2+) influx in T cells by a novel mechanism independent of protein kinase C activation.
Topics: Animals; Calcium Signaling; Cyclohexanones; Diglycerides; Enzyme Activation; Enzyme Inhibitors; In Vitro Techniques; Lipoprotein Lipase; Mice; Mice, Inbred BALB C; Naphthalenes; Nickel; Protein Kinase C; Pyrimidinones; Receptors, Antigen, T-Cell; T-Lymphocytes; Thiazoles | 2000 |
Modulation of low-threshold T-type calcium channels by the five muscarinic receptor subtypes in NIH 3T3 cells.
Topics: 3T3 Cells; 8-Bromo Cyclic Adenosine Monophosphate; Acetylcholine; Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Colforsin; Cyclic AMP; Enzyme Inhibitors; Gene Expression; Membrane Potentials; Mice; Naphthalenes; Nickel; Nifedipine; Patch-Clamp Techniques; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptor, Muscarinic M4; Receptor, Muscarinic M5; Receptors, Muscarinic; Thionucleotides; Transfection; Vasodilator Agents | 2000 |